A photocatalytic water treatment technology using mesoporous titanium dioxide decorated with sub-nanometer metal co-catalysts. The system accelerates breakdown of organic contaminants up to 30 times faster than unmodified TiO2 under UV light, offering an efficient approach for degrading organic pollutants and biological molecules in water.
This technology addresses the challenge of removing organic contaminants from water through photocatalysis. By decorating mesoporous titanium dioxide (M-TiO2) with sub-nanometer metal particles (SNMs) that act as co-catalysts, the system significantly accelerates the degradation of organic molecules when exposed to UV light. Compared to using M-TiO2 alone, the SNM-decorated photocatalysts degrade organic dyes approximately 30 times faster. The approach builds on prior success in treating wastewater from wine production and is being extended toward cleaning water containing biological molecules relevant to household and industrial applications.
Key features:
How it works:
The technology has been validated in laboratory experiments demonstrating a 30-fold increase in dye degradation rate compared to unmodified M-TiO2. Future validation will focus on preparing a broader range of SNM/M-TiO2 material combinations, testing photocatalytic degradation of biological molecules relevant to household water cleaning, and identifying the most efficient metal cluster co-catalyst. The use of commercially available raw materials supports a clear pathway toward scale-up and practical deployment.
Flinders University is a comprehensive public research university based in Adelaide with a growing footprint across South Australia. Its Tonsley campus sits inside the Tonsley Innovation District, placing researchers alongside industry, government, and startups in facilities designed for co-development and demonstration. The health and medical precinct integrates the university with Flinders Medical Centre and a new Health & Medical Research Building, enabling rapid clinical collaboration and translation. Research is supported by competitive funding from the Australian Research Council, the National Health and Medical Research Council, and the Medical Research Future Fund. A dedicated research partnerships and commercialisation team and an active entrepreneurship institute help industry engage, manage IP, and launch new ventures.